Norges Bank’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-278,011
| Closed | -$32.9M | – | 2306 |
|
|
2021
Q1 | $32.9M | Sell |
278,011
-33,842
| -11% | -$4M | 0.01% | 1233 |
|
|
2020
Q4 | $36.8M | Hold |
311,853
| – | – | 0.01% | 1181 |
|
|
2020
Q3 | $34.7M | Sell |
311,853
-56,948
| -15% | -$6.11M | 0.01% | 1066 |
|
|
2020
Q2 | $37.7M | Sell |
368,801
-8,600
| -2% | -$920K | 0.01% | 1036 |
|
|
2020
Q1 | $40.7M | Sell |
377,401
-25,862
| -6% | -$2.97M | 0.01% | 800 |
|
|
2019
Q4 | $46.9M | Hold |
403,263
| – | – | 0.01% | 958 |
|
|
2019
Q3 | $46.2M | Hold |
403,263
| – | – | 0.01% | 913 |
|
|
2019
Q2 | $38.4M | Hold |
403,263
| – | – | 0.01% | 1048 |
|
|
2019
Q1 | $36.8M | Buy |
403,263
+99,188
| +33% | +$8.12M | 0.01% | 1069 |
|
|
2018
Q4 | $23.1M | Hold |
304,075
| – | – | 0.01% | 1301 |
|
|
2018
Q3 | $24.3M | Buy |
304,075
+39,944
| +15% | +$3.72M | 0.01% | 1416 |
|
|
2018
Q2 | $26.2M | Hold |
264,131
| – | – | 0.01% | 1330 |
|
|
2018
Q1 | $21.4M | Hold |
264,131
| – | – | 0.01% | 1385 |
|
|
2017
Q4 | $20.8M | Hold |
264,131
| – | – | 0.01% | 1444 |
|
|
2017
Q3 | $24.4M | Buy |
264,131
+18,980
| +8% | +$1.82M | 0.01% | 1312 |
|
|
2017
Q2 | $27.7M | Buy |
245,151
+7,266
| +3% | +$812K | 0.01% | 1166 |
|
|
2017
Q1 | $23.8M | Buy |
237,885
+11,507
| +5% | +$1.23M | 0.01% | 1274 |
|
|
2016
Q4 | $24.3M | Hold |
226,378
| – | – | 0.01% | 1188 |
|
|
2016
Q3 | $26.9M | Buy |
226,378
+19,950
| +10% | +$2.36M | 0.01% | 1019 |
|
|
2016
Q2 | $21.9M | Buy |
206,428
+40,421
| +24% | +$4.69M | 0.01% | 1147 |
|
|
2016
Q1 | $19M | Buy |
166,007
+29,900
| +22% | +$3.51M | 0.01% | 1185 |
|
|
2015
Q4 | $19.4M | Buy |
136,107
+94,407
| +226% | +$10.9M | 0.01% | 1182 |
|
|
2015
Q3 | $3.75M | Buy |
+41,700
| New | +$4.4M | ﹤0.01% | 1926 |
|
Norges Bank's CBPO Position: Q2 2021 in Review
Norges Bank sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 278,011 shares — an estimated $32.9M sold.
Norges Bank first reported a position in CBPO in Q3 2015 and held it in 23 quarters. The position peaked at $46.9M in Q4 2019. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Norges Bank reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Norges Bank sold 278,011 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $32.9M.
- Norges Bank first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 23 quarters.
- Norges Bank's China Biologic Products Holdings, Inc. position peaked at $46.9M in Q4 2019.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Norges Bank's 13F filing for Q2 2021, filed 10 Aug 2021.